Minglin Zhu

Design, synthesis and anti-inflammatory evaluation of novel pyrrolo[2,3-d]pyrimidin derivatives as potent JAK inhibitors.

X. Zhai, L. Zang, Nan Jiang, 2019, Bioorganic & medicinal chemistry.

Structure guided design of potent indole-based ATX inhibitors bearing hydrazone moiety with tumor suppression effects.

X. Zhai, Nan Jiang, Ming-juan Guo, 2020, European journal of medicinal chemistry.

Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants.

X. Zhai, Tong Li, Ming-juan Guo, 2020, Bioorganic & medicinal chemistry.

Optimization and evaluation of novel tetrahydropyrido[4,3-d]pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis.

X. Zhai, Junlong Zhang, Nan Jiang, 2019, European journal of medicinal chemistry.

An exploration of solvent-front region high affinity moiety leading to novel potent ALK & ROS1 dual inhibitors with mutant-combating effects.

X. Zhai, Daiying Zuo, Ming-juan Guo, 2019, Bioorganic & medicinal chemistry.

An efficient and practical protocol for the production of pretomanid (PA-824) via a novel synthetic strategy

Xin Zhai, Ming Guo, Minglin Zhu, 2020, Chemical Papers.